Last update 01 Nov 2024

MaaT-033

Overview

Basic Info

Drug Type
Live biotherapeutic products
Synonyms
Target-
Mechanism
Bacteria replacements, Gastrointestinal microbiome modulators
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2/3
First Approval Date-
RegulationOrphan Drug (EU)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Axial SpondyloarthritisPhase 3
FR
28 Mar 2024
Hematopoietic stem cell transplantationPhase 2
DE
31 Oct 2023
Hematopoietic stem cell transplantationPhase 2
FR
31 Oct 2023
Transplant complicationPhase 2
DE
31 Oct 2023
Transplant complicationPhase 2
FR
31 Oct 2023
Amyotrophic Lateral SclerosisPhase 1
FR
08 Jun 2023
Acute Myeloid LeukemiaPhase 1--
Hematologic NeoplasmsIND Approval
FR
27 Mar 2023
Hematologic NeoplasmsIND Approval
DE
27 Mar 2023
Hematologic DiseasesDiscovery
FR
20 Oct 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
20
(mhxatemksz) = The DSMB, composed of 5 independent experts, reviewed safety data on the first 20 patients (cutoff date as of April 30th, 2024) and concluded that safety was acceptable and well tolerated. sggsifbyvg (ppgofziqha )
Positive
03 Jul 2024
Phase 1
8
(dfbxznddwx) = MaaT033 has shown a good safety profile and was generally well tolerated in the first 8 patients with ALS treated with MaaT033 used in a chronic setting. nntplusxud (oovyrzquvg )
Positive
29 Feb 2024
Phase 1
21
(ljifvuualg) = yqdxdtfsac oncsyzobdt (ntcikagcmt )
Positive
15 Nov 2022
Phase 1
21
(dnaftkvoro) = an infectious diarrhea event with no detection of the causal pathogen in the administered MaaT033 and patient recovery within four days ghfdrxqodl (ssgurjoduq )
Positive
02 Jun 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free